| Dr Christina Danielle Hahn, MD | |
|
Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 | |
| (314) 590-5423 | |
| Not Available |
| Full Name | Dr Christina Danielle Hahn |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | Landstuhl Regional Medical Center, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730233446 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 01060549A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christina Danielle Hahn, MD Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Ph: (314) 590-5423 | Dr Christina Danielle Hahn, MD Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Ph: (314) 590-5423 |
News Archive
As the COVID-19 pandemic rages across the world, killing hundreds of thousands and infecting over 4.1 million, researchers are racing against time to understand the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 genome has now been sequenced in many different regions of the world, and researchers are collaborating by sharing information to better understand the make-up and mutations that the virus has undergone.
Scientists who examined more than 10,000 chemical compounds during the last year in search of potential new drugs for a group of untreatable brain diseases, are reporting that one substance shows unusual promise.
Rapidly cooling a person in cardiac arrest may improve their chance of survival without brain damage, according to research presented at the American Heart Association's Scientific Sessions 2009.
Researchers at the RIKEN Center for Genomic Medicine (CGM), together with colleagues at Kyoto University, Tsukuba University, Harvard University, and other medical institutions have identified three new loci associated with susceptibility to adult asthma in the Japanese population.
Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer.
› Verified 5 days ago
Dr. Zia Ahmad Dehqanzada, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Cmr 442, Box 291, Apo, AE 09042 Phone: 496-221-173440 Fax: 496-221-173427 | |
Dr. Jeremy David Simmons, MD Surgery Medicare: Medicare Enrolled Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-8220 | |
Nicole Rachael Laferriere, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-5851 | |
Katherine Cameron, MD Surgery Medicare: Medicare Enrolled Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-7872 | |
Dr. Mary F Stuever, D.O Surgery Medicare: Accepting Medicare Assignments Practice Location: Unit 33100, Apo, AE 09180 Phone: 317-590-7171 | |
Dr. Thach Pham, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-5096 | |
Patrick Benoit, D.O Surgery Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 301-295-4000 |